For instance, a higher expression of ASCL1, Dll1, Notch1, -3, -4, and Hey1 correlates with a higher glioma grade and a worse prognosis [78,79,80,81], indicating that more activated Notch signaling promotes a more undifferentiated and aggressive tumor phenotype. This evidence concerns the gene NOTCH1 and central nervous system cancer.